BWA
GBT

BDO Wealth Advisors’s Global Blood Therapeutics, Inc. GBT Stock Holding History

BDO Wealth Advisors’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-20
Closed -$1K – 720
2019
Q1 		$1K Sell
20
-40
-67% -$1.97K ﹤0.01% 604
2018
Q4 		$2K Hold
60
– – ﹤0.01% 511
2018
Q3 		$2K Hold
60
– – ﹤0.01% 580
2018
Q2 		$3K Buy
60
+30
+100% +$1.37K ﹤0.01% 563
2018
Q1 		$1K Sell
30
-30
-50% -$1.67K ﹤0.01% 564
2017
Q4 		$2K Buy
+60
New +$2.24K ﹤0.01% 440

Other funds holding GBT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BDO Wealth Advisors's GBT Position: Q2 2019 in Review

BDO Wealth Advisors sold out of Global Blood Therapeutics, Inc. (GBT) in Q2 2019, closing a stake of 20 shares — an estimated $1K sold.

BDO Wealth Advisors first reported a position in GBT in Q4 2017 and held it in 6 quarters. The position peaked at $3K in Q2 2018. 223 funds tracked by Wall St. Rank hold GBT as of Q2 2019.

  • BDO Wealth Advisors reported no remaining Global Blood Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
  • BDO Wealth Advisors sold 20 Global Blood Therapeutics, Inc. shares in Q2 2019, an estimated $1K.
  • BDO Wealth Advisors first reported a position in Global Blood Therapeutics, Inc. in Q4 2017 and held it in 6 quarters.
  • BDO Wealth Advisors's Global Blood Therapeutics, Inc. position peaked at $3K in Q2 2018.
  • 223 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q2 2019.

Based on BDO Wealth Advisors's 13F filing for Q2 2019, filed 9 Aug 2019.